Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hurteloup

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Hematology and Cell Therapy|October 1, 1996
Treatment of acute myeloblastic leukemia in adults. The GOELAM experienceJ L Harousseau, B Pignon, F Witz, et al.
Bulletin Du Cancer|January 1, 1982
[Metastatic breast carcinoma: sequential hormonotherapy with tamoxifen and medroxy-progesterone acetate. preliminary results]J F Bosset, M Pereal, P Hurteloup, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of oral idarubicin in elderly patients with advanced breast cancerB Chevallier, A Monnier, R Metz, et al.
Investigational New Drugs|January 1, 1984
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemiaM Hayat, P Hurteloup, C Parmentier, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTCP Hurteloup, P Chollet, H Roche, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with IdarubicinC Parmentier, M Finaud, M Schlumberger, et al.
Leukemia & Lymphoma|January 29, 2011
Oral idarubicin and low dose cytarabine as the initial treatment of acute myeloid leukemia in elderly patientsJ L Harousseau, F Huguet, J Reiffers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabineJ L Harousseau, J Reiffers, P Hurteloup, et al.
Cancer Treatment Reports|June 1, 1986
Phase II clinical evaluation of doxifluridineP Hurteloup, J P Armand, P Cappelaere, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of CancerP Hurteloup, J P Armand, M Schneider, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Hematology and Cell Therapy|October 1, 1996
Treatment of acute myeloblastic leukemia in adults. The GOELAM experienceJ L Harousseau, B Pignon, F Witz, et al.
Bulletin Du Cancer|January 1, 1982
[Metastatic breast carcinoma: sequential hormonotherapy with tamoxifen and medroxy-progesterone acetate. preliminary results]J F Bosset, M Pereal, P Hurteloup, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of oral idarubicin in elderly patients with advanced breast cancerB Chevallier, A Monnier, R Metz, et al.
Investigational New Drugs|January 1, 1984
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemiaM Hayat, P Hurteloup, C Parmentier, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTCP Hurteloup, P Chollet, H Roche, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with IdarubicinC Parmentier, M Finaud, M Schlumberger, et al.
Leukemia & Lymphoma|January 29, 2011
Oral idarubicin and low dose cytarabine as the initial treatment of acute myeloid leukemia in elderly patientsJ L Harousseau, F Huguet, J Reiffers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabineJ L Harousseau, J Reiffers, P Hurteloup, et al.
Cancer Treatment Reports|June 1, 1986
Phase II clinical evaluation of doxifluridineP Hurteloup, J P Armand, P Cappelaere, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of CancerP Hurteloup, J P Armand, M Schneider, et al.
Pageof 4